Pharming Group N.V. ADR (PHAR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 376,134 | 297,200 | 245,316 | 205,622 | 198,871 |
| Cost of Goods | 45,500 | 35,399 | 25,212 | 17,562 | 21,142 |
| Gross Profit | 330,634 | 261,801 | 220,104 | 188,060 | 177,729 |
| Operating Expenses | 305,292 | 270,821 | 225,703 | 170,389 | 164,310 |
| Operating Income | 25,842 | -8,621 | -5,387 | 18,233 | 13,561 |
| Other Income | -12,995 | 129 | -6,625 | -3,246 | 9,517 |
| Pre-tax Income | 12,847 | -8,492 | -12,012 | 14,987 | 23,078 |
| Income Tax | 10,310 | 3,349 | -1,464 | 1,313 | 7,082 |
| Net Income Continuous | 2,537 | -11,841 | -10,548 | 13,674 | 15,996 |
| Minority Interests | -313 | N/A | N/A | N/A | N/A |
| Net Income | $2,851 | $-11,841 | $-10,548 | $13,674 | $15,996 |
| EPS Basic Total Ops | 0.04 | -0.18 | -0.16 | 0.21 | 0.25 |
| EPS Basic Continuous Ops | 0.04 | -0.18 | -0.16 | 0.21 | 0.25 |
| EPS Diluted Total Ops | 0.04 | -0.18 | -0.16 | 0.19 | 0.23 |
| EPS Diluted Continuous Ops | 0.03 | -0.15 | -0.15 | 0.19 | 0.23 |
| EPS Diluted Before Non-Recurring Items | 0.04 | -0.16 | -0.14 | 0.03 | 0.19 |
| EBITDA(a) | $37,058 | $7,449 | $10,538 | $31,421 | $33,171 |